• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Anaesthesist . Recommendations for treatment of critically ill patients with COVID-19 : Version 3 S1 guideline

tetano

Editor, Senior Moderator
Anaesthesist


. 2020 Nov 27;1-11.
doi: 10.1007/s00101-020-00879-3. Online ahead of print.
Recommendations for treatment of critically ill patients with COVID-19 : Version 3 S1 guideline


S Kluge[SUP] 1 2 3 4 5 [/SUP], U Janssens[SUP] 6 7 8 [/SUP], T Welte[SUP] 6 9 8 [/SUP], S Weber-Carstens[SUP] 7 10 8 [/SUP], G Sch?lte[SUP] 10 [/SUP], B Salzberger[SUP] 11 [/SUP], P Gastmeier[SUP] 12 [/SUP], F Langer[SUP] 13 [/SUP], M Welper[SUP] 10 [/SUP], M Westhoff[SUP] 9 [/SUP], M Pfeifer[SUP] 9 [/SUP], F Hoffmann[SUP] 7 14 [/SUP], B W B?ttiger[SUP] 7 15 [/SUP], G Marx[SUP] 7 10 8 [/SUP], C Karagiannidis[SUP] 6 7 9 8 [/SUP]



Affiliations

Abstract

Since December 2019 a novel coronavirus (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2) has rapidly spread around the world resulting in an acute respiratory illness pandemic. The immense challenges for clinicians and hospitals as well as the strain on many healthcare systems has been unprecedented.The majority of patients present with mild symptoms of coronavirus disease 2019 (COVID-19); however, 5-8% become critically ill and require intensive care treatment. Acute hypoxemic respiratory failure with severe dyspnea and an increased respiratory rate (>30/min) usually leads to intensive care unit (ICU) admission. At this point bilateral pulmonary infiltrates are typically seen. Patients often develop a severe acute respiratory distress syndrome (ARDS).So far, remdesivir and dexamethasone have shown clinical effectiveness in severe COVID-19 in hospitalized patients. The main goal of supportive treatment is to ascertain adequate oxygenation. Invasive mechanical ventilation and repeated prone positioning are key elements in treating severely hypoxemic COVID-19 patients.Strict adherence to basic infection control measures (including hand hygiene) and correct use of personal protection equipment (PPE) are essential in the care of patients. Procedures that lead to formation of aerosols should be carried out with utmost precaution and preparation.
 
Back
Top Bottom